Literature DB >> 12729719

Purification and characterization of a soluble form of rat liver NADPH-cytochrome P-450 reductase highly expressed in Escherichia coli.

Shunsuke Hayashi1, Yoshiaki Omata, Hiroshi Sakamoto, Takayuki Hara, Masato Noguchi.   

Abstract

A recombinant cDNA of rat liver NADPH-cytochrome P-450 reductase (CPR), which lacks the N-terminal hydrophobic region, was amplified by PCR and cloned. The N-truncated cDNA named tCPR was ligated into a pBAce vector and expressed. The tCPR protein expressed in Escherichia coli was recovered into the soluble fraction of the cell lysate and purified to homogeneity by three sequential purification procedures; (I) anion-exchange chromatography on a DEAE-cellulose (DE-52) column, (II) affinity chromatography on 2('),5(')-ADP Sepharose 4B, and (III) chromatography on a hydroxyapatite column. The average yield was 47mg per liter of culture medium. The absorption spectrum of the purified tCPR protein was identical to that of a native full-length CPR purified from rat liver, indicating that tCPR also possesses one molecule each of FAD and FMN. The tCPR protein was able to reduce cytochrome c and was also able to assist heme degradation by a soluble form of rat heme oxygenase-1. However, it failed to support the O-deethylation of 7-ethoxycoumarin by cytochrome P-450 1A1, indicating that the presence of the N-terminal hydrophobic domain is necessary for CPR to interact with cytochrome P-450. Previously, to prepare a soluble form of CPR, full-length CPR was treated with proteinases that selectively removed the N-terminal domain. With the expression system established in this study, however, the soluble and biologically active tCPR protein can be readily prepared in large amounts. This expression system will be useful for mechanistic as well as structural studies of CPR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12729719     DOI: 10.1016/s1046-5928(03)00023-8

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  14 in total

1.  Effect of homomeric P450-P450 complexes on P450 function.

Authors:  James R Reed; J Patrick Connick; Dongmei Cheng; George F Cawley; Wayne L Backes
Journal:  Biochem J       Date:  2012-09-15       Impact factor: 3.857

2.  Novel Substrate Specificity and Temperature-Sensitive Activity of Mycosphaerella graminicola CYP51 Supported by the Native NADPH Cytochrome P450 Reductase.

Authors:  Claire L Price; Andrew G S Warrilow; Josie E Parker; Jonathan G L Mullins; W David Nes; Diane E Kelly; Steven L Kelly
Journal:  Appl Environ Microbiol       Date:  2015-03-06       Impact factor: 4.792

3.  High-yield expression of a catalytically active membrane-bound protein: human P450 oxidoreductase.

Authors:  Duanpen Sandee; Walter L Miller
Journal:  Endocrinology       Date:  2011-05-17       Impact factor: 4.736

4.  FMN binding site of yeast NADPH-cytochrome P450 reductase exposed at the surface is highly specific.

Authors:  Alexis S Ivanov; Oksana V Gnedenko; Andrey A Molnar; Alexander I Archakov; Larissa M Podust
Journal:  ACS Chem Biol       Date:  2010-08-20       Impact factor: 5.100

5.  Structural basis for the electron transfer from an open form of NADPH-cytochrome P450 oxidoreductase to heme oxygenase.

Authors:  Masakazu Sugishima; Hideaki Sato; Yuichiro Higashimoto; Jiro Harada; Kei Wada; Keiichi Fukuyama; Masato Noguchi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-03       Impact factor: 11.205

6.  Inhibition of CYP2B4 by the mechanism-based inhibitor 2-ethynylnaphthalene: inhibitory potential of 2EN is dependent on the size of the substrate.

Authors:  Dongmei Cheng; James R Reed; Danni Harris; Wayne L Backes
Journal:  Arch Biochem Biophys       Date:  2007-04-09       Impact factor: 4.013

7.  Inhibition of CYP2B4 by 2-ethynylnaphthalene: evidence for the co-binding of substrate and inhibitor within the active site.

Authors:  Dongmei Cheng; Danni Harris; James R Reed; Wayne L Backes
Journal:  Arch Biochem Biophys       Date:  2007-10-04       Impact factor: 4.013

8.  Mass spectrometric identification of lysine residues of heme oxygenase-1 that are involved in its interaction with NADPH-cytochrome P450 reductase.

Authors:  Yuichiro Higashimoto; Masakazu Sugishima; Hideaki Sato; Hiroshi Sakamoto; Keiichi Fukuyama; Graham Palmer; Masato Noguchi
Journal:  Biochem Biophys Res Commun       Date:  2008-01-14       Impact factor: 3.575

Review 9.  Role of protein-protein interactions in cytochrome P450-mediated drug metabolism and toxicity.

Authors:  Sylvie E Kandel; Jed N Lampe
Journal:  Chem Res Toxicol       Date:  2014-08-29       Impact factor: 3.739

10.  Co-expression of active human cytochrome P450 1A2 and cytochrome P450 reductase on the cell surface of Escherichia coli.

Authors:  Paul Quehl; Joel Hollender; Jan Schüürmann; Tatjana Brossette; Ruth Maas; Joachim Jose
Journal:  Microb Cell Fact       Date:  2016-02-02       Impact factor: 5.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.